As Washington Clamps Down on Big Pharma, Small Is Beautiful Again
Large drug companies need innovation to deal with the drug-pricing law. That is a boon to smaller biotech firms.
Large drug companies need innovation to deal with the drug-pricing law. That is a boon to smaller biotech firms.
MarketsFinancial RegulationProsecutors and regulators say healthcare company executive tipped friend to company’s drug approval